Toby J. Phesse

4.9k total citations · 1 hit paper
44 papers, 3.1k citations indexed

About

Toby J. Phesse is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Toby J. Phesse has authored 44 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 19 papers in Oncology and 10 papers in Surgery. Recurrent topics in Toby J. Phesse's work include Wnt/β-catenin signaling in development and cancer (25 papers), Cancer-related gene regulation (16 papers) and Helicobacter pylori-related gastroenterology studies (9 papers). Toby J. Phesse is often cited by papers focused on Wnt/β-catenin signaling in development and cancer (25 papers), Cancer-related gene regulation (16 papers) and Helicobacter pylori-related gastroenterology studies (9 papers). Toby J. Phesse collaborates with scholars based in United Kingdom, Australia and United States. Toby J. Phesse's co-authors include Alan R. Clarke, Owen J. Sansom, Elizabeth Vincan, Dustin J. Flanagan, Hans Clevers, Matthias Ernst, Vanesa Muncan, Karen R. Reed, Valérie S. Méniel and Julie A. Wilkins and has published in prestigious journals such as Nature, Nature Communications and Gastroenterology.

In The Last Decade

Toby J. Phesse

42 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

gp130-Mediated Stat3 Activation in Enterocytes Regulates Cell Survival and Cell-Cycle Progression during Colitis-Associated Tumorigenesis

2009 780 citations Toby J. Phesse, Tracy L. Putoczki et al. profile →

Peers

Countries citing papers authored by Toby J. Phesse

Since Specialization

Citations

This map shows the geographic impact of Toby J. Phesse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toby J. Phesse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toby J. Phesse more than expected).

Fields of papers citing papers by Toby J. Phesse

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toby J. Phesse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toby J. Phesse. The network helps show where Toby J. Phesse may publish in the future.

Co-authorship network of co-authors of Toby J. Phesse

This figure shows the co-authorship network connecting the top 25 collaborators of Toby J. Phesse. A scholar is included among the top collaborators of Toby J. Phesse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toby J. Phesse. Toby J. Phesse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The αvβ6 integrin specific virotherapy, Ad5NULL-A20.FCU1, selectively delivers potent “in-tumour” chemotherapy to pancreatic ductal adenocarcinoma 2024 ·British Journal of Cancer ·Luned Badder, (unknown), Valérie S. Méniel, (unknown), (unknown), (unknown), Toby J. Phesse, Catherine Hogan, Alan L. Parker	0
2	Development and Characterisation of a New Patient-Derived Xenograft Model of AR-Negative Metastatic Castration-Resistant Prostate Cancer 2024 ·Cells ·(unknown), (unknown), Nicholas Bullock, Kathryn Gilroy, (unknown), Radhika A. Patel, (unknown), Valérie S. Méniel, Gillian Seaton, Howard Kynaston, Richard Clarkson, Toby J. Phesse, Peter S. Nelson, Michael C. Haffner, John Staffurth, Helen Pearson	1
3	The scaffolding protein flot2 promotes cytoneme-based transport of wnt3 in gastric cancer 2022 ·eLife ·(unknown), Sally Rogers, Yosuke Ono, Lucy Brunt, Valérie S. Méniel, Giusy Tornillo, Hassan Ashktorab, Toby J. Phesse, Steffen Scholpp	13
4	Development of a low-seroprevalence, αvβ6 integrin-selective virotherapy based on human adenovirus type 10 2022 ·Molecular Therapy — Oncolytics ·Emily A. Bates, James A. Davies, (unknown), (unknown), Valérie S. Méniel, Sarah Koushyar, (unknown), (unknown), (unknown), Hanni Uusi-Kerttula, Alexander T. Baker, David K. Cole, Dragomira Majhen, P.J. Rizkallah, Toby J. Phesse, John Chester, Alan L. Parker	6
5	The Hepatitis B Virus Pre-Core Protein p22 Activates Wnt Signaling 2020 ·Cancers ·(unknown), Dustin J. Flanagan, Gregor Ebert, Nadia Warner, Hoanh Tran, Theodora Fifis, (unknown), Christopher Christophi, Marc Pellegrini, Joseph Torresi, Toby J. Phesse, Elizabeth Vincan	15
6	Frizzled-7 Is Required for Wnt Signaling in Gastric Tumors with and Without Apc Mutations 2019 ·Cancer Research ·Dustin J. Flanagan, Nick Barker, (unknown), Elizabeth A. Mason, Austin Gurney, Valérie S. Méniel, Sarah Koushyar, (unknown), Matthias Ernst, Helen Pearson, Alex Boussioutas, Hans Clevers, Toby J. Phesse, Elizabeth Vincan	84
7	IL-33-mediated mast cell activation promotes gastric cancer through macrophage mobilization 2019 ·Nature Communications ·Moritz F. Eissmann, Christine D. Dijkstra, Andrew Jarnicki, Toby J. Phesse, (unknown), Ashleigh R. Poh, Nima Etemadi, Evelyn Tsantikos, Stefan Thiem, Nicholas D. Huntington, Margaret L. Hibbs, Alex Boussioutas, Michele A. Grimbaldeston, Michael Büchert, Robert J.J. O’Donoghue, Frédérick Masson, Matthias Ernst	161
8	Identification of Pik3ca Mutation as a Genetic Driver of Prostate Cancer That Cooperates with Pten Loss to Accelerate Progression and Castration-Resistant Growth 2018 ·Cancer Discovery ·Helen Pearson, Jason Li, Valérie S. Méniel, Christina M. Fennell, Paul Waring, Karen G. Montgomery, Richard J. Rebello, (unknown), Sarah Koushyar, Luc Furic, Carleen Cullinane, Richard Clarkson, Matthew J. Smalley, Kaylene J. Simpson, Toby J. Phesse, Peter R. Shepherd, Patrick O. Humbert, Owen J. Sansom, Wayne A. Phillips	78
9	The Central Role of Wnt Signaling and Organoid Technology in Personalizing Anticancer Therapy 2017 ·Progress in molecular biology and translational science ·Elizabeth Vincan, Renate Schwab, Dustin J. Flanagan, (unknown), (unknown), Nick Barker, Toby J. Phesse	8
10	Lgr5 joins the club of gastric stem cell markers in the corpus 2017 ·Nature Cell Biology ·Toby J. Phesse, Owen J. Sansom	18
11	Dual Targeting of Bromodomain and Extraterminal Domain Proteins, and WNT or MAPK Signaling, Inhibits c-MYC Expression and Proliferation of Colorectal Cancer Cells 2016 ·Molecular Cancer Therapeutics ·Lars Tögel, (unknown), Anderly C. Chüeh, Aparna Jayachandran, Hoanh Tran, Toby J. Phesse, Rui Wu, Oliver M. Sieber, Diego Arango, Amardeep S. Dhillon, Mark A. Dawson, Beatriz Díez-Dacal, Timothy C. Gahman, P. Filippakopoulos, Andrew K. Shiau, John M. Mariadason	74
12	Isolation and Culture of Adult Intestinal, Gastric, and Liver Organoids for Cre-recombinase-Mediated Gene Deletion 2016 ·Methods in molecular biology ·Dustin J. Flanagan, Renate Schwab, (unknown), Toby J. Phesse, Elizabeth Vincan	8
13	The polarity protein Scrib mediates epidermal development and exerts a tumor suppressive function during skin carcinogenesis 2015 ·Molecular Cancer ·Helen Pearson, Edwina McGlinn, Toby J. Phesse, Holger Schlüter, (unknown), Nathan Gödde, (unknown), Anthony J. Ryan, Wayne A. Phillips, Matthias Ernst, Pritinder Kaur, Patrick O. Humbert	30
14	Therapeutic Inhibition of Jak Activity Inhibits Progression of Gastrointestinal Tumors in Mice 2014 ·Molecular Cancer Therapeutics ·Emma Stuart, Michael Büchert, Tracy L. Putoczki, Stefan Thiem, Ryan Farid, (unknown), Dennis Huszar, Paul Waring, Toby J. Phesse, Matthias Ernst	28
15	Scrib heterozygosity predisposes to lung cancer and cooperates with KRas hyperactivation to accelerate lung cancer progression in vivo 2013 ·Oncogene ·Imogen Elsum, Laura L. Yates, Helen Pearson, Toby J. Phesse, Fei Long, Robert J.J. O’Donoghue, Matthias Ernst, Carleen Cullinane, Patrick O. Humbert	46
16	Focal Adhesion Kinase Is Required for Intestinal Regeneration and Tumorigenesis Downstream of Wnt/c-Myc Signaling 2010 ·Developmental Cell ·G H S Ashton, Jennifer P. Morton, Kevin Myant, Toby J. Phesse, Rachel A. Ridgway, Victoria Marsh, Julie A. Wilkins, Dimitris Athineos, Vanesa Muncan, Richard Kemp, Kristi L. Neufeld, Hans Clevers, Valerie G. Brunton, Douglas J. Winton, Xiaoyan Wang, Rosalie C. Sears, Alan R. Clarke, Margaret C. Frame, Owen J. Sansom	153
17	Liver Zonation Occurs Through a β-Catenin–Dependent, c-Myc–Independent Mechanism 2009 ·Gastroenterology ·Zoë D. Burke, Karen R. Reed, Toby J. Phesse, Owen J. Sansom, Alan R. Clarke, David Tosh	116
18	K-ras and Wnt Signaling Synergize to Accelerate Prostate Tumorigenesis in the Mouse 2008 ·Cancer Research ·Helen Pearson, Toby J. Phesse, Alan R. Clarke	65
19	Myc deletion rescues Apc deficiency in the small intestine 2007 ·Nature ·Owen J. Sansom, Valérie S. Méniel, Vanesa Muncan, Toby J. Phesse, Julie A. Wilkins, Karen R. Reed, J. Keith Vass, Dimitris Athineos, Hans Clevers, Alan R. Clarke	468
20	Rapid Loss of Intestinal Crypts upon Conditional Deletion of the Wnt/Tcf-4 Target Gene c-Myc 2006 ·Molecular and Cellular Biology ·Vanesa Muncan, Owen J. Sansom, Leon G.J. Tertoolen, Toby J. Phesse, Harry Begthel, Elena Sancho, Alicia M. Cole, Alex Gregorieff, Ignacio Moreno de Alborán, Hans Clevers, Alan R. Clarke	203

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact